FocalTherics CEO to Present at H.C. Wainwright Conference

  • FocalTherics CEO Ryan Rhodes to present at H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026.
  • CFO Ken Mobeck to host 1x1 investor meetings on September 15-16, 2026.
  • Presentation scheduled for 10:30-11:00 AM ET on September 15, 2026.
  • Live and archived webcast available via FocalTherics' investor relations page.

FocalTherics' participation in the H.C. Wainwright conference underscores its strategic focus on engaging with investors and showcasing its technological advancements. The company's flagship Focal One® Robotic HIFU platform positions it at the forefront of minimally invasive medical treatments, a sector experiencing rapid growth driven by demand for personalized and less invasive therapeutic options. The conference provides a critical platform for the company to communicate its vision and address any market concerns.

Market Positioning
How FocalTherics will leverage this conference to strengthen its position as a global leader in robotic focal therapy.
Investor Sentiment
Whether the 1x1 investor meetings will generate renewed interest or skepticism about the company's growth prospects.
Technological Advancements
The pace at which FocalTherics can innovate and scale its proprietary focused ultrasound technology.